SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

Description

This is a prospective, randomized, multi-center clinical trial for chronic kidney disease (CKD) patients referred for creation of a new arteriovenous fistula (AVF) in order to assess the safety and effectiveness of SelfWrap, a bioabsorbable perivascular wrap.

Conditions

Chronic Kidney Diseases, End Stage Renal Disease, Arteriovenous Fistula, Hemodialysis Access Failure, ESRD, Vascular Access Complication, Renal Failure, Catheter Complications, Catheter Dysfunction, Renal Insufficiency

Study Overview

Study Details

Study overview

This is a prospective, randomized, multi-center clinical trial for chronic kidney disease (CKD) patients referred for creation of a new arteriovenous fistula (AVF) in order to assess the safety and effectiveness of SelfWrap, a bioabsorbable perivascular wrap.

SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

Condition
Chronic Kidney Diseases
Intervention / Treatment

-

Contacts and Locations

Marana

AKDHC Marana Surgery Center, Marana, Arizona, United States, 85658

Phoenix

Arizona Kidney Disease & Hypertension Centers (AKDHC) Phoenix Surgery Center, Phoenix, Arizona, United States, 85012

Tucson

Banner University Medical Center, Tucson, Arizona, United States, 85724

Fort Wayne

Lutheran Medical Group, Fort Wayne, Indiana, United States, 46804

Columbia

University of Missouri, Columbia, Missouri, United States, 65212

Charlotte

Surgical Specialists of Charlotte, PA, Charlotte, North Carolina, United States, 28226

Raleigh

WakeMed, Raleigh, North Carolina, United States, 27610

Orangeburg

Medical University of South Carolina (MUSC) Orangeburg / Dialysis Access Institute, Orangeburg, South Carolina, United States, 29118

Austin

Cardiothoracic and Vascular Surgeons, Austin, Texas, United States, 78756

Houston

Houston Methodist Research Institute, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age of at least 18 years
  • * Referred for creation of a new AVF
  • * Willing and able to comply with study requirements, communicate with the study team, and attend follow up visits over a period of 36 months
  • * Planned index procedure to revise or repair an existing fistula
  • * Target artery inner diameter \< 2.0 mm, as measured by ultrasound while the target arm is under tourniquet pressure and anesthesia
  • * Target vein inner diameter \< 2.0 mm, as measured by ultrasound while the target arm is under tourniquet pressure and anesthesia
  • * Significant (at least 50%) stenosis at the target vein on the side of surgery (between the planned anastomosis site and the axillary vein), as diagnosed by preoperative ultrasound
  • * Known central venous stenosis of at least 50% on the side of surgery
  • * Presence of a stent or a stent graft within the access circuit
  • * Known or suspected coagulation disorder that, in the opinion of the Investigator, puts too much risk on the patient for AVF creation
  • * Known or suspected active infection at the time of surgery
  • * Congestive heart failure NYHA class 4
  • * Prior steal on the side of surgery;
  • * Enrolled in another investigational drug, device, or biological study, or was previously enrolled in this study
  • * Life expectancy less than 12 months
  • * Expected to undergo kidney transplant surgery within 6 months of enrollment
  • * Expected to undergo home hemodialysis
  • * Females of childbearing potential (premenopausal and not surgically sterile) without documented current negative pregnancy test at screening
  • * Presence of a comorbid condition that, in the opinion of the Investigator, may significantly confound the collection of safety and efficacy data in this study
  • * Unwillingness or inability to give consent and/or comply with the study follow up schedule
  • * Any health condition, which in the opinion of the Investigator, would interfere with the safety of the participant or the participant's ability to comply with the study.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

VenoStent,

Timothy Boire, PhD, STUDY_DIRECTOR, VenoStent, Inc.

Study Record Dates

2027-12